Company Filing History:
4 out of 5 
3 out of 1,744 
1 out of 73 Years Active: 2010-2021
Title: Jing Wang: Innovator in Tinnitus Treatment
Introduction
Jing Wang is a prominent inventor based in Lunel, France, known for her significant contributions to the field of audiology, particularly in the treatment of tinnitus. With a total of 5 patents to her name, she has made remarkable strides in developing innovative methods to address this challenging condition.
Latest Patents
One of her latest patents focuses on methods for the treatment of tinnitus induced by cochlear excitotoxicity. This invention involves administering a pharmaceutical composition that includes an NMDA receptor antagonist to individuals suffering from tinnitus. The treatment is designed for local administration to the inner ear using appropriate devices and formulations. The tinnitus targeted by this invention may arise from various causes, including acoustic trauma, presbycusis, ischemia, anoxia, and the use of ototoxic medications. Additionally, her patent outlines a novel screening method that incorporates an electrophysiological test to identify compounds effective in treating and preventing tinnitus.
Career Highlights
Throughout her career, Jing Wang has worked with notable organizations such as Auris Medical AG and the Institut National de la Santé et de la Recherche Médicale. Her work has significantly impacted the understanding and treatment of tinnitus, showcasing her dedication to improving patient outcomes.
Collaborations
Jing has collaborated with esteemed colleagues in her field, including Jean-Luc Puel and Matthieu Guitton. These partnerships have further enhanced her research and development efforts in tinnitus treatment.
Conclusion
Jing Wang's innovative approaches to treating tinnitus highlight her commitment to advancing medical science. Her contributions continue to pave the way for new therapeutic options for individuals affected by this condition.